Pasar al contenido principal

BIOINFORMATICA ESTRUCTURAL PARA EL DESARROLLO DE NUEVOS FARMACOS CONTRA ENFERMEDADES TROPICALES OLVIDADAS

BFU2010-19310

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2010
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario FUNDACIÓN DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRÍNCIPE FELIPE
Identificador persistente http://dx.doi.org/10.13039/501100004837

BIOINFORMATICA ESTRUCTURAL PARA EL DESARROLLO DE NUEVOS FARMACOS CONTRA ENFERMEDADES TROPICALES OLVIDADAS

BFU2010-19310

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2010
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario FUNDACIÓ PARC CIENTIFIC DE BARCELONA
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Assessing the limits of restraint-based 3D modeling of genomes and genomic domains

  • Trussart, Marie, 1985-
  • Serra, François
  • Baù, Davide
  • Junier, Ivan
  • Serrano Pubull, Luis, 1982-
  • Martí Renom, Marc A.
Restraint-based modeling of genomes has been recently explored with the advent of Chromosome Conformation Capture (3C-based) experiments. We previously developed a reconstruction method to resolve the 3D architecture of both prokaryotic and eukaryotic genomes using 3C-based data. These models were congruent with fluorescent imaging validation. However, the limits of such methods have not systematically been assessed. Here we propose the first evaluation of a mean-field restraint-based reconstruction of genomes by considering diverse chromosome architectures and different levels of data noise and structural variability. The results show that: first, current scoring functions for 3D reconstruction correlate with the accuracy of the models; second, reconstructed models are robust to noise but sensitive to structural variability; third, the local structure organization of genomes, such as Topologically Associating Domains, results in more accurate models; fourth, to a certain extent, the models capture the intrinsic structural variability in the input matrices and fifth, the accuracy of the models can be a priori predicted by analyzing the properties of the interaction matrices. In summary, our work provides a systematic analysis of the limitations of a mean-field restrain-based method, which could be taken into consideration in further development of methods as well as their applications., Spanish Ministerio de Economía y Competitividad [BFU2010–19310, BFU2013–47736-P to M.A.M.-R., BIO2007–61762 to L.S.]; European Research Council [609989 to M.A.M.-R., 232913 to L.S.]; Human Frontiers Science Program [RGP0044 to M.A.M.-R.]; Spanish Instituto de Salud Carlos III [PI10/01702 to L.S.]; Fundación Marcelino Botin (to L.S.). Funding for open access charge: ERC Synergy [609989].
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Rational design of non-resistant targeted cancer therapies

  • Martínez-Jiménez, Francisco, 1988-
  • Overington, John P.
  • Al-Lazikani, Bissan
  • Martí Renom, Marc A.
Drug resistance is one of the major problems in targeted cancer therapy. A major cause of resistance is changes in the amino acids that form the drug-target binding site. Despite of the numerous efforts made to individually understand and overcome these mutations, there is a lack of comprehensive analysis of the mutational landscape that can prospectively estimate drug-resistance mutations. Here we describe and computationally validate a framework that combines the cancer-specific likelihood with the resistance impact to enable the detection of single point mutations with the highest chance to be responsible of resistance to a particular targeted cancer therapy. Moreover, for these treatment-threatening mutations, the model proposes alternative therapies overcoming the resistance. We exemplified the applicability of the model using EGFR-gefitinib treatment for Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Cancer (LSCC) and the ERK2-VTX11e treatment for melanoma and colorectal cancer. Our model correctly identified the phenotype known resistance mutations, including the classic EGFR-T790M and the ERK2-P58L/S/T mutations. Moreover, the model predicted new previously undescribed mutations as potentially responsible of drug resistance. Finally, we provided a map of the predicted sensitivity of alternative ERK2 and EGFR inhibitors, with a particular highlight of two molecules with a low predicted resistance impact., The project was supported by the Spanish MINECO to M.A.M.-R. (BFU2010-19310). We also acknowledge the support of the Spanish Ministry of Economy and Competitiveness, Centro de Excelencia Severo Ochoa 2013-2017 (SEV-2012-0208) and the CERCA Programme of the Generalitat de Catalunya.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The conformation of yeast chromosome III is mating type dependent and controlled by the recombination enhancer

  • Belton, Jon-Matthew
  • Lajoie, Bryan R.
  • Audibert, Sylvain
  • Cantaloube, Sylvain
  • Lassadi, Imen
  • Goiffon, Isabelle
  • Baù, Davide
  • Marti-Renom, Marc A.
  • Bystricky, Kerstin
  • Dekker, Job
Mating-type switching in yeast occurs through gene conversion between the MAT locus and one of two silent loci (HML or HMR) on opposite ends of the chromosome. MATa cells choose HML as template, whereas MATα cells use HMR. The recombination enhancer (RE) located on the left arm regulates this process. One long-standing hypothesis is that switching is guided by mating-type-specific and possibly RE-dependent chromosome folding. Here, we use Hi-C, 5C, and live-cell imaging to characterize the conformation of chromosome III in both mating types. We discovered a mating-type-specific conformational difference in the left arm. Deletion of a 1-kb subregion within the RE, which is not necessary during switching, abolished mating-type-dependent chromosome folding. The RE is therefore a composite element with one subregion essential for donor selection during switching and a separate region involved in modulating chromosome conformation., We acknowledge financial support from the National Human Genome Research Institute (HG003143) to J.D.; the Human Frontiers Science Program (RGP0044/2011) to J.D., K.B., and M.A.M.-R.; the Spanish MINECO (BFU2010-19310/BMC and BFU2013-47736-P) to M.A.M.-R.; and the French ANR (SVSE5 ANDY) to K.B. J.D. is an investigator of the Howard Hughes Medical Institute.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation

  • Le Dily, François
  • Baù, Davide
  • Pohl, Andy, 1979-
  • Vicent, Guillermo P.
  • Serra, François
  • Soronellas, Daniel
  • Castellano, Giancarlo
  • Wright, Roni H.G.
  • Ballare, Cecilia Julia
  • Filion, Guillaume
  • Marti-Renom, Marc A.
  • Beato, Miguel
Includes supplementary materials for the online appendix., The human genome is segmented into topologically associating domains (TADs), but the role of this conserved organization during transient changes in gene expression is not known. Here we describe the distribution of progestin-induced chromatin modifications and changes in transcriptional activity over TADs in T47D breast cancer cells. Using ChIP-seq (chromatin immunoprecipitation combined with high-throughput sequencing), Hi-C (chromosome capture followed by high-throughput sequencing), and three-dimensional (3D) modeling techniques, we found that the borders of the ∼ 2000 TADs in these cells are largely maintained after hormone treatment and that up to 20% of the TADs could be considered as discrete regulatory units where the majority of the genes are either transcriptionally activated or repressed in a coordinated fashion. The epigenetic signatures of the TADs are homogeneously modified by hormones in correlation with the transcriptional changes. Hormone-induced changes in gene activity and chromatin remodeling are accompanied by differential structural changes for activated and repressed TADs, as reflected by specific and opposite changes in the strength of intra-TAD interactions within responsive TADs. Indeed, 3D modeling of the Hi-C data suggested that the structure of TADs was modified upon treatment. The differential responses of TADs to progestins and estrogens suggest that TADs could function as "regulons" to enable spatially proximal genes to be coordinately transcribed in response to hormones., We acknowledge financial support from the Spanish Ministry of Economy and Competitiveness (MINECO) (BFU2010-19310/BMC) and the Human Frontiers Science Program (RGP0044/2011) (to M.A.M.-R.). This work was also supported by grants from the Spanish government (BMC 2003-02902, BMC 2010-15313, and CSD2006-00049) and the Catalan government (Agència de Gestió d’Ajuts Universitaris i de Recerca [AGAUR]) (to M.B.). We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017,’ SEV-2012-0208. F.L.D., G.F., M.A.M-R., and M.B. designed the studies. F.L.D. performed Hi-C, FISH, and RNA-seq experiments. G.V., R.H.G.W, and C.B. performed ChIP-seq experiments. F.L.D. carried out the data analysis with contributions from A.P., D.S., G.C., and G.F., and F.S., D.B., and M.A.M-R. carried out the 3D modelling and analysis. F.S. and G.F. designed the TAD boundary algorithm. All of the authors discussed the results, and F.L.D., M.A.M-R., and M.B. wrote the manuscript.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Chromatin and RNA maps reveal regulatory long noncoding RNAs in mouse

  • Bogu, Gireesh K., 1984-
  • Vizán, Pedro
  • Stanton, Lawrence W.
  • Beato, Miguel
  • Di Croce, Luciano
  • Marti-Renom, Marc A.
Discovering and classifying long noncoding RNAs (lncRNAs) across all mammalian tissues and cell lines remains a major challenge. Previously, mouse lncRNAs were identified using transcriptome sequencing (RNA-seq) data from a limited number of tissues or cell lines. Additionally, associating a few hundred lncRNA promoters with chromatin states in a single mouse cell line has identified two classes of chromatin-associated lncRNA. However, the discovery and classification of lncRNAs is still pending in many other tissues in mouse. To address this, we built a comprehensive catalog of lncRNAs by combining known lncRNAs with high-confidence novel lncRNAs identified by mapping and de novo assembling billions of RNA-seq reads from eight tissues and a primary cell line in mouse. Next, we integrated this catalog of lncRNAs with multiple genome-wide chromatin state maps and found two different classes of chromatin state-associated lncRNAs, including promoter-associated (plncRNAs) and enhancer-associated (elncRNAs) lncRNAs, across various tissues. Experimental knockdown of an elncRNA resulted in the downregulation of the neighboring protein-coding Kdm8 gene, encoding a histone demethylase. Our findings provide 2,803 novel lncRNAs and a comprehensive catalog of chromatin-associated lncRNAs across different tissues in mouse., This work was supported by the Spanish MINECO BFU2010-19310, BFU2013-47736-P, Spanish MINECO SAF2013-48926-P, Centro de Excelencia Severo Ochoa 2013-2017SEV-2012-0208
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation

  • Le Dily, François
  • Bau, Davide
  • Pohl, Andy
  • Vicent, Guillermo P.
  • Serra, Francois
  • Soronellas, Daniel
  • Castellano, Giancarlo
  • Wright, Roni
  • Ballare, Cecilia
  • Filion, Guillaume
  • Marti-Renom, Marc A.
  • Beato, Miguel
We thank the Centre de Regulació Genòmica (CRG) Ultrasequencing Unit and Advanced Light Microscopy Unit for technical support, and all members of the Chromatin and Gene Expression and Structural Genomic groups for helpful discussions. We acknowledge Juan Valcarcel for his helpful comments on the manuscript. We also thank Marta Morell and the Genetic Causes of Disease group for providing the BAC clones used in this study. We thank Ivan Junier for his help and advice in normalizing the Hi-C data. We acknowledge financial support from the Spanish Ministry of Economy and Competitiveness (MINECO) (BFU2010-19310/BMC) and the Human Frontiers Science Program (RGP0044/2011) (to M.A.M.-R.). This work was also supported by grants from the Spanish government (BMC 2003-02902, BMC 2010-15313, and CSD2006-00049) and the Catalan government (Agència de Gestió d’Ajuts Universitaris i de Recerca [AGAUR]) (to M.B.). We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017,’ SEV-2012-0208. F.L.D., G.F., M.A.M-R., and M.B. designed the studies. F.L.D. performed Hi-C, FISH, and RNA-seq experiments. G.V., R.H.G.W, and C.B. performed ChIP-seq experiments. F.L.D. carried out the data analysis with contributions from A.P., D.S., G.C., and G.F., and F.S., D.B., and M.A.M-R. carried out the 3D modelling and analysis. F.S. and G.F. designed the TAD boundary algorithm. All of the authors discussed the results, and F.L.D., M.A.M-R., and M.B. wrote the manuscript., The human genome is segmented into topologically associating domains (TADs), but the role of this conserved organization during transient changes in gene expression is not known. Here we describe the distribution of progestin-induced chromatin modifications and changes in transcriptional activity over TADs in T47D breast cancer cells. Using ChIP-seq (chromatin immunoprecipitation combined with high-throughput sequencing), Hi-C (chromosome capture followed by high-throughput sequencing), and three-dimensional (3D) modeling techniques, we found that the borders of the ∼2000 TADs in these cells are largely maintained after hormone treatment and that up to 20% of the TADs could be considered as discrete regulatory units where the majority of the genes are either transcriptionally activated or repressed in a coordinated fashion. The epigenetic signatures of the TADs are homogeneously modified by hormones in correlation with the transcriptional changes. Hormone-induced changes in gene activity and chromatin remodeling are accompanied by differential structural changes for activated and repressed TADs, as reflected by specific and opposite changes in the strength of intra-TAD interactions within responsive TADs. Indeed, 3D modeling of the Hi-C data suggested that the structure of TADs was modified upon treatment. The differential responses of TADs to progestins and estrogens suggest that TADs could function as “regulons” to enable spatially proximal genes to be coordinately transcribed in response to hormones., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Assessing the limits of restraint-based 3D modeling of genomes and genomic domains

  • Trussart, Marie, 1985-
  • Serra, François
  • Baù, Davide
  • Junier, Ivan
  • Serrano Pubull, Luis, 1982-
  • Martí Renom, Marc A.
Restraint-based modeling of genomes has been recently explored with the advent of Chromosome Conformation Capture (3C-based) experiments. We previously developed a reconstruction method to resolve the 3D architecture of both prokaryotic and eukaryotic genomes using 3C-based data. These models were congruent with fluorescent imaging validation. However, the limits of such methods have not systematically been assessed. Here we propose the first evaluation of a mean-field restraint-based reconstruction of genomes by considering diverse chromosome architectures and different levels of data noise and structural variability. The results show that: first, current scoring functions for 3D reconstruction correlate with the accuracy of the models; second, reconstructed models are robust to noise but sensitive to structural variability; third, the local structure organization of genomes, such as Topologically Associating Domains, results in more accurate models; fourth, to a certain extent, the models capture the intrinsic structural variability in the input matrices and fifth, the accuracy of the models can be a priori predicted by analyzing the properties of the interaction matrices. In summary, our work provides a systematic analysis of the limitations of a mean-field restrain-based method, which could be taken into consideration in further development of methods as well as their applications., Spanish Ministerio de Economía y Competitividad [BFU2010–19310, BFU2013–47736-P to M.A.M.-R., BIO2007–61762 to L.S.]; European Research Council [609989 to M.A.M.-R., 232913 to L.S.]; Human Frontiers Science Program [RGP0044 to M.A.M.-R.]; Spanish Instituto de Salud Carlos III [PI10/01702 to L.S.]; Fundación Marcelino Botin (to L.S.). Funding for open access charge: ERC Synergy [609989].
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The conformation of yeast chromosome III is mating type dependent and controlled by the recombination enhancer

  • Belton, Jon-Matthew
  • Lajoie, Bryan R.
  • Audibert, Sylvain
  • Cantaloube, Sylvain
  • Lassadi, Imen
  • Goiffon, Isabelle
  • Baù, Davide
  • Marti-Renom, Marc A.
  • Bystricky, Kerstin
  • Dekker, Job
Mating-type switching in yeast occurs through gene conversion between the MAT locus and one of two silent loci (HML or HMR) on opposite ends of the chromosome. MATa cells choose HML as template, whereas MATα cells use HMR. The recombination enhancer (RE) located on the left arm regulates this process. One long-standing hypothesis is that switching is guided by mating-type-specific and possibly RE-dependent chromosome folding. Here, we use Hi-C, 5C, and live-cell imaging to characterize the conformation of chromosome III in both mating types. We discovered a mating-type-specific conformational difference in the left arm. Deletion of a 1-kb subregion within the RE, which is not necessary during switching, abolished mating-type-dependent chromosome folding. The RE is therefore a composite element with one subregion essential for donor selection during switching and a separate region involved in modulating chromosome conformation., We acknowledge financial support from the National Human Genome Research Institute (HG003143) to J.D.; the Human Frontiers Science Program (RGP0044/2011) to J.D., K.B., and M.A.M.-R.; the Spanish MINECO (BFU2010-19310/BMC and BFU2013-47736-P) to M.A.M.-R.; and the French ANR (SVSE5 ANDY) to K.B. J.D. is an investigator of the Howard Hughes Medical Institute.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation

  • Le Dily, François
  • Baù, Davide
  • Pohl, Andy, 1979-
  • Vicent, Guillermo P.
  • Serra, François
  • Soronellas, Daniel
  • Castellano, Giancarlo
  • Wright, Roni H.G.
  • Ballare, Cecilia Julia
  • Filion, Guillaume
  • Marti-Renom, Marc A.
  • Beato, Miguel
Includes supplementary materials for the online appendix., The human genome is segmented into topologically associating domains (TADs), but the role of this conserved organization during transient changes in gene expression is not known. Here we describe the distribution of progestin-induced chromatin modifications and changes in transcriptional activity over TADs in T47D breast cancer cells. Using ChIP-seq (chromatin immunoprecipitation combined with high-throughput sequencing), Hi-C (chromosome capture followed by high-throughput sequencing), and three-dimensional (3D) modeling techniques, we found that the borders of the ∼ 2000 TADs in these cells are largely maintained after hormone treatment and that up to 20% of the TADs could be considered as discrete regulatory units where the majority of the genes are either transcriptionally activated or repressed in a coordinated fashion. The epigenetic signatures of the TADs are homogeneously modified by hormones in correlation with the transcriptional changes. Hormone-induced changes in gene activity and chromatin remodeling are accompanied by differential structural changes for activated and repressed TADs, as reflected by specific and opposite changes in the strength of intra-TAD interactions within responsive TADs. Indeed, 3D modeling of the Hi-C data suggested that the structure of TADs was modified upon treatment. The differential responses of TADs to progestins and estrogens suggest that TADs could function as "regulons" to enable spatially proximal genes to be coordinately transcribed in response to hormones., We acknowledge financial support from the Spanish Ministry of Economy and Competitiveness (MINECO) (BFU2010-19310/BMC) and the Human Frontiers Science Program (RGP0044/2011) (to M.A.M.-R.). This work was also supported by grants from the Spanish government (BMC 2003-02902, BMC 2010-15313, and CSD2006-00049) and the Catalan government (Agència de Gestió d’Ajuts Universitaris i de Recerca [AGAUR]) (to M.B.). We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017,’ SEV-2012-0208. F.L.D., G.F., M.A.M-R., and M.B. designed the studies. F.L.D. performed Hi-C, FISH, and RNA-seq experiments. G.V., R.H.G.W, and C.B. performed ChIP-seq experiments. F.L.D. carried out the data analysis with contributions from A.P., D.S., G.C., and G.F., and F.S., D.B., and M.A.M-R. carried out the 3D modelling and analysis. F.S. and G.F. designed the TAD boundary algorithm. All of the authors discussed the results, and F.L.D., M.A.M-R., and M.B. wrote the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Chromatin and RNA maps reveal regulatory long noncoding RNAs in mouse

  • Bogu, Gireesh K., 1984-
  • Vizán, Pedro
  • Stanton, Lawrence W.
  • Beato, Miguel
  • Di Croce, Luciano
  • Marti-Renom, Marc A.
Discovering and classifying long noncoding RNAs (lncRNAs) across all mammalian tissues and cell lines remains a major challenge. Previously, mouse lncRNAs were identified using transcriptome sequencing (RNA-seq) data from a limited number of tissues or cell lines. Additionally, associating a few hundred lncRNA promoters with chromatin states in a single mouse cell line has identified two classes of chromatin-associated lncRNA. However, the discovery and classification of lncRNAs is still pending in many other tissues in mouse. To address this, we built a comprehensive catalog of lncRNAs by combining known lncRNAs with high-confidence novel lncRNAs identified by mapping and de novo assembling billions of RNA-seq reads from eight tissues and a primary cell line in mouse. Next, we integrated this catalog of lncRNAs with multiple genome-wide chromatin state maps and found two different classes of chromatin state-associated lncRNAs, including promoter-associated (plncRNAs) and enhancer-associated (elncRNAs) lncRNAs, across various tissues. Experimental knockdown of an elncRNA resulted in the downregulation of the neighboring protein-coding Kdm8 gene, encoding a histone demethylase. Our findings provide 2,803 novel lncRNAs and a comprehensive catalog of chromatin-associated lncRNAs across different tissues in mouse., This work was supported by the Spanish MINECO BFU2010-19310, BFU2013-47736-P, Spanish MINECO SAF2013-48926-P, Centro de Excelencia Severo Ochoa 2013-2017SEV-2012-0208
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Rational design of non-resistant targeted cancer therapies

  • Martínez-Jiménez, Francisco, 1988-
  • Overington, John P.
  • Al-Lazikani, Bissan
  • Martí Renom, Marc A.
Drug resistance is one of the major problems in targeted cancer therapy. A major cause of resistance is changes in the amino acids that form the drug-target binding site. Despite of the numerous efforts made to individually understand and overcome these mutations, there is a lack of comprehensive analysis of the mutational landscape that can prospectively estimate drug-resistance mutations. Here we describe and computationally validate a framework that combines the cancer-specific likelihood with the resistance impact to enable the detection of single point mutations with the highest chance to be responsible of resistance to a particular targeted cancer therapy. Moreover, for these treatment-threatening mutations, the model proposes alternative therapies overcoming the resistance. We exemplified the applicability of the model using EGFR-gefitinib treatment for Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Cancer (LSCC) and the ERK2-VTX11e treatment for melanoma and colorectal cancer. Our model correctly identified the phenotype known resistance mutations, including the classic EGFR-T790M and the ERK2-P58L/S/T mutations. Moreover, the model predicted new previously undescribed mutations as potentially responsible of drug resistance. Finally, we provided a map of the predicted sensitivity of alternative ERK2 and EGFR inhibitors, with a particular highlight of two molecules with a low predicted resistance impact., The project was supported by the Spanish MINECO to M.A.M.-R. (BFU2010-19310). We also acknowledge the support of the Spanish Ministry of Economy and Competitiveness, Centro de Excelencia Severo Ochoa 2013-2017 (SEV-2012-0208) and the CERCA Programme of the Generalitat de Catalunya.